On October 2, 2019, the Board of Directors of Novelion Therapeutics Inc. elected Michael D. Price to serve as a director on the Novelion Board, with a term that expires at Novelion's upcoming annual general meeting (the Annual Meeting). The Novelion Board will be recommending that Mr. Price be elected by the Novelion shareholders for another term at the upcoming Annual Meeting. Mr. Price was not, and is not expected to be, appointed to any committees of the Novelion Board.